CK Life Sciences Intl Holdings Inc (0775)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 0.505 |
|---|---|
| 52-week range | 0.505 – 1.020 |
| Return, 1 month / 3 months | −8.2% / −12.9% |
| Return, 1 year / 3 years | −48.5% / −27.9% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 36.4% |
| Worst drawdown (1 year) | -50.0% |
| Average daily value traded | 2.28M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CK Life Sciences Intl Holdings Inc is a biotechnology company based in Hong Kong that develops, manufactures and markets health and wellness products. Its consumer business sells nutritional supplements and personal care items under its own brands, while its pharmaceutical arm works on prescription medicines and related research. The company also applies biotechnology to environmental and agricultural products, including crop and soil treatments. Customers include consumers, healthcare distributors and agricultural users across several markets.
On this site CK Life Sciences Intl Holdings Inc appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 0775, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CK Life Sciences Intl Holdings Inc (0775) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 0.505 on 21 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 1,586 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 48.5% and over the last three months it fell 12.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -25.8% | ||
| From 52-week high | -50.0% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.9% | ||
| 6-month return | -29.9% | ||
| 12-month return, skipping the last month | -43.9% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.0% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.28M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −5.6% |
|---|---|
| 1 month | −8.2% |
| 3 months | −12.9% |
| 6 months | −29.9% |
| 1 year | −48.5% |
| 3 years | −27.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.555 / 0.681 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.014 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 May 2023 | HKD 0.0080 |
| 20 May 2022 | HKD 0.0100 |
| 18 May 2021 | HKD 0.0100 |
| 19 May 2020 | HKD 0.0100 |
| 21 May 2019 | HKD 0.0100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.